Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials.

Autor: Ren J; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA., Dewey RB 3rd; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, 33486, USA., Rynders A; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Evan J; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Evan J; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Ligozio S; Instat Clinical Research, A Veristat Company, 1 Wilson St., Chatham, NJ, 07928, USA., Ho KS; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA. karen@clene.com., Sguigna PV; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA., Glanzman R; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Hotchkin MT; 3Clene Nanomedicine, Inc., 6550 S Millrock Dr., Suite G50, Salt Lake City, UT, 84121, USA., Dewey RB Jr; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, 33486, USA., Greenberg BM; Department of Neurology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Jazyk: angličtina
Zdroj: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jan 03; Vol. 22 (1), pp. 16. Date of Electronic Publication: 2024 Jan 03.
DOI: 10.1186/s12951-023-02269-4
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje